{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:10:54Z","timestamp":1793229054685,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.msec.2020.111103","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T04:40:25Z","timestamp":1589949625000},"page":"111103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis"],"prefix":"10.1016","volume":"116","author":[{"given":"Rakesh Kumar","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Vyawahare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shadab","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2020.111103_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msec.2017.07.037","article-title":"Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber","volume":"81","author":"Gopi","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111103_bb0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ijbiomac.2017.02.024","article-title":"Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-\u03ba\u0412 activation","volume":"98","author":"Lv","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.msec.2020.111103_bb0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/17474124.2018.1503052","article-title":"Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East","volume":"12","author":"Sharara","year":"2018","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1016\/j.msec.2020.111103_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2018.12.046","article-title":"Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy","volume":"557","author":"Chen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.111103_bb0025","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1002\/ijc.32037","article-title":"Colitis\u2010induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity","volume":"12","author":"Ibrahim","year":"2019","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.msec.2020.111103_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/14728214.2015.1002768","article-title":"Emerging drugs for the treatment of cervical cancer","volume":"20","author":"Serrano-Olvera","year":"2015","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1016\/j.msec.2020.111103_bb0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.21037\/tp.2018.12.03","article-title":"Personalising medicine in inflammatory bowel disease\u2014current and future perspectives","volume":"8","author":"Ashton","year":"2019","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.msec.2020.111103_bb0040","first-page":"3204","article-title":"Current treatment of ulcerative colitis","volume":"17","author":"Meier","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msec.2020.111103_bb0045","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/gast.1997.v112.pm9041264","article-title":"Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years","volume":"112","author":"Wallace","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.msec.2020.111103_bb0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejpb.2018.07.026","article-title":"In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration","volume":"131","author":"van Midwoud","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2020.111103_bb0055","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2147\/JPR.S186000","article-title":"Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis","volume":"11","author":"Shin","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.msec.2020.111103_bb0060","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msec.2020.111103_bb0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/mt.2014.222","article-title":"Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli","volume":"23","author":"Spisni","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.msec.2020.111103_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113558","article-title":"Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles","volume":"9","author":"Cooper","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111103_bb0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin. Ther."},{"key":"10.1016\/j.msec.2020.111103_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/950981","article-title":"Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection","volume":"2013","author":"Pereira","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.msec.2020.111103_bb0085","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1080\/10717544.2016.1178824","article-title":"Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro\u2013in-vivo evaluation","volume":"23","author":"Bazan","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.msec.2020.111103_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.msec.2020.111103_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3702518","article-title":"Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"key":"10.1016\/j.msec.2020.111103_bb0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2020.111103_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5762431","article-title":"Recent progress on nanostructures for drug delivery applications","volume":"2016","author":"Lu","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.msec.2020.111103_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0068-3","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"4","author":"Singh","year":"2019","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.msec.2020.111103_bb0115","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.msec.2020.111103_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.msec.2020.111103_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11094-019-02017-9","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: emerging lipid based drug delivery systems","volume":"53","author":"Shirodkar","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.msec.2020.111103_bb0130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/molecules23040982","article-title":"Development of triamcinolone acetonide-loaded nanostructured lipid carriers (NLCs) for buccal drug delivery using the Box-Behnken design","volume":"23","author":"Kraisit","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.msec.2020.111103_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-973X.167661","article-title":"Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs","volume":"5","author":"Khan","year":"2015","journal-title":"International Journal of Pharmaceutical Investigation"},{"key":"10.1016\/j.msec.2020.111103_bb0140","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/10717544.2018.1529209","article-title":"Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy","volume":"25","author":"Cirri","year":"2018","journal-title":"Drug Delivery"},{"key":"10.1016\/j.msec.2020.111103_bb0145","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/acs.jafc.6b04409","article-title":"Biocompatible lipid nanoparticles as carriers to improve curcumin efficacy in ovarian cancer treatment","volume":"65","author":"Bond\u00ec","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.msec.2020.111103_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.06.002","article-title":"Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells","volume":"361","author":"Zhang","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2020.111103_bb0155","first-page":"487","article-title":"In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system","volume":"5","author":"Wang","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.msec.2020.111103_bb0160","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2018.07.019","article-title":"Therapeutic effect of vitamin D3-containing nanostructured lipid carriers on inflammatory bowel disease","volume":"286","author":"Zai","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2020.111103_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/21691401.2014.909822","article-title":"Nanostructured lipid carriers and their current application in targeted drug delivery","volume":"44","author":"Jaiswal","year":"2016","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"10.1016\/j.msec.2020.111103_bb0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jddst.2017.06.013","article-title":"Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs","volume":"42","author":"Beloqui","year":"2017","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.msec.2020.111103_bb0175","first-page":"215","article-title":"Effects of variations in physicochemical properties of glyceryl monostearate on the stability of an oil-in water cream","volume":"40","author":"Sachs","year":"1989","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.msec.2020.111103_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tiv.2008.12.014","article-title":"Plant derived antioxidants \u2013 geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress","volume":"23","author":"Tiwari","year":"2009","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.msec.2020.111103_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bfopcu.2015.10.001","article-title":"Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride","volume":"53","author":"Gaba","year":"2015","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University"},{"key":"10.1016\/j.msec.2020.111103_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.msec.2020.111103_bb0195","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/acsbiomaterials.8b01081","article-title":"Gelatin-coated Polycaprolactone nanoparticle-mediated Naringenin delivery rescue human mesenchymal stem cells from oxygen glucose deprivation-induced inflammatory stress","volume":"5","author":"Ahmad","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.msec.2020.111103_bb0200","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2147\/IJN.S46613","article-title":"Hyaluronan\u2013cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin\/alginate microbeads for colon drug delivery","volume":"8","author":"Tsai","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.msec.2020.111103_bb0205","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/acs.biomac.7b01607","article-title":"Nanocarrier composed of magnetite core coated with three polymeric shells mediates LCS-1 delivery for synthetic lethal therapy of BLM-defective colorectal cancer cells","volume":"19","author":"Gupta","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.msec.2020.111103_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46671-1","article-title":"Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression","volume":"9","author":"Abdelmegid","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msec.2020.111103_bb0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2016.01.012","article-title":"Garlic oil inhibits dextran sodium sulfate-induced ulcerative colitis in rats","volume":"146","author":"Balaha","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.msec.2020.111103_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jnutbio.2016.12.019","article-title":"Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice","volume":"42","author":"Islam","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.msec.2020.111103_bb0225","article-title":"Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111103_bb0230","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/ibd.21625","article-title":"Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation","volume":"17","author":"Larsson","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.msec.2020.111103_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024447","article-title":"On the relationship between sialomucin and sulfomucin expression and hydrogenotrophic microbes in the human colonic mucosa","volume":"6","author":"Croix","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msec.2020.111103_bb0240","doi-asserted-by":"crossref","first-page":"1131S","DOI":"10.1093\/ajcn\/73.6.1131S","article-title":"Microbial modulation of innate defense: goblet cells and the intestinal mucus layer","volume":"73","author":"Deplancke","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.msec.2020.111103_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/432493","article-title":"Relationship between mast cells and the colitis with relapse induced by trinitrobenzesulphonic acid in Wistar rats","author":"Luchini","year":"2009","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.msec.2020.111103_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9524075","article-title":"Role of histamine in modulating the immune response and inflammation","author":"Branco","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.msec.2020.111103_bb0255","first-page":"1","article-title":"Anti-inflammatory effect of fucoxanthin on dextran sulfate sodium-induced colitis in mice","author":"Yang","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.msec.2020.111103_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071843","article-title":"iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats","volume":"8","author":"Schreiber","year":"2013","journal-title":"PLoS One"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493120304057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493120304057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:09:00Z","timestamp":1760533740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493120304057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":52,"alternative-id":["S0928493120304057"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2020.111103","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2020.111103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111103"}}